New Zealand markets closed

Hestia Insight Inc. (HSTA)

OTC Markets OTCQB - OTC Markets OTCQB Delayed price. Currency in USD
Add to watchlist
0.16000.0000 (0.00%)
At close: 11:49AM EDT
Full screen
Trade prices are not sourced from all markets
Previous close0.1600
Open0.1600
Bid0.1000 x 0
Ask0.1600 x 0
Day's range0.1600 - 0.1600
52-week range0.1100 - 1.0200
Volume1,000
Avg. volume411
Market cap4.47M
Beta (5Y monthly)0.08
PE ratio (TTM)N/A
EPS (TTM)-0.0200
Earnings dateN/A
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
  • GlobeNewswire

    Hestia Insight Inc. Subsidiary Enters Into Corporate Advisory Agreement With Aquiva Medical Inc.

    LAS VEGAS, NV, March 21, 2024 (GLOBE NEWSWIRE) -- via NewMediaWire -- Hestia Insight Inc. (OTCQB: HSTA) ("Hestia Insight" and the “Company”), a company focused on the development and operation of novel technologies in the healthcare and biotech sectors, and providing marketing, management, business, and capital markets advisory services to its clients within the healthcare and biotech sectors, today announced that through its wholly owned subsidiary, Hestia Investments Inc., the Company entered

  • GlobeNewswire

    Hestia Insight Inc. Unveils Innovative Marketing Plan to Assist Emerging Companies

    LAS VEGAS, NV, Dec. 21, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – Hestia Insight Inc. (OTCQB: HSTA) ("Hestia Insight" and the “Company”), a company focused on the development and operation of novel technologies and providing marketing, management, business, and capital markets advisory services to its clients, today announced the launch of its new marketing plan - a strategic initiative designed to empower emerging growth companies by integrating professional expertise, top-tier talent, and AI

  • GlobeNewswire

    Hestia Insight Inc. Announces Upcoming Launch of AI-Powered IR Website Platform to Assist Start-Ups, Small and Medium Sized Companies

    NEW YORK, NY, Aug. 29, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire - Hestia Insight Inc. (OTCQB: HSTA) (“Hestia Insight” and the “Company”), a company focused on the development and operation of novel technologies in the healthcare and biotech sectors, and providing marketing, management, business, and capital markets advisory services to its clients within the healthcare and biotech sectors, today announced that in September 2023, its wholly owned subsidiary, Hestia Investments Inc. (“Hestia Inve